Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis in the primate ovary.

H M Fraser1, C Wulff

  • 1MRC Human Reproductive Sciences Unit, Centre for Reproductive Biology, Edinburgh, UK. h.fraser@hrsu.mrc.ac.uk

Reproduction, Fertility, and Development
|May 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lichen Sclerosis is Associated With a High Rate of Local Failure After Radio(chemo)therapy for Vulvar Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Neurodevelopmental disorder in children believed to have isolated mild ventriculomegaly prenatally.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2018
Same author

Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability.

Geburtshilfe und Frauenheilkunde·2017
Same author

Regulation of Endothelial Permeability in the Corpus Luteum: A Review of the Literature.

Geburtshilfe und Frauenheilkunde·2014
Same author

[Not Available].

Mycotoxin research·2013
Same author

Contrast imaging ultrasound detects abnormalities in the marmoset ovary.

American journal of primatology·2012

This article examines how blood vessel formation, or angiogenesis, is regulated in the primate ovary. Using marmoset monkeys, researchers show that blocking specific growth factors disrupts normal ovarian development and function, suggesting new ways to influence fertility.

Area of Science:

  • Reproductive biology research within Angiogenesis studies
  • Primate endocrinology and ovarian physiology

Background:

The mechanisms driving cyclic vascular remodeling in the female reproductive system remain incompletely understood. Prior research has shown that ovarian tissues undergo rapid morphological shifts during each reproductive cycle. That uncertainty drove the need for reliable animal models to track these vascular changes. Scientists have long sought to identify the specific molecular signals governing these tissue transformations. No prior work had resolved how primates regulate these complex physiological events in vivo. Previous studies often relied on non-primate models that failed to capture human-like follicular dynamics. This gap motivated the selection of the marmoset monkey for detailed investigation. The current paper addresses this by establishing a framework for observing ovarian vascularization in a primate species.

Purpose Of The Study:

The aim of this research is to characterize the cellular and molecular regulation of vascular development within the primate ovary. This investigation addresses the requirement for a robust model to study cyclic ovarian changes. The authors seek to elucidate the effects of manipulating specific angiogenic factors on reproductive function. Understanding these processes is vital for clarifying how follicles and the corpus luteum mature. The study explores whether blocking key signaling molecules can alter normal physiological outcomes. Researchers intend to quantify vascular expansion and cell proliferation across the ovulatory cycle. This work provides insights into the interactions between vascular growth and follicular development. The project ultimately evaluates the potential for controlling reproductive processes through targeted molecular intervention.

Keywords:
folliculogenesisVEGFluteal phasereproductive physiologyendothelial cells

Frequently Asked Questions

The researchers propose that VEGF inhibition suppresses endothelial cell proliferation, which subsequently triggers a decline in granulosa cell growth and prevents the maturation of the luteal microvascular tree.

The study utilizes the marmoset monkey as an in vivo model to monitor changes in blood vessel area and endothelial cell proliferation throughout the ovulatory cycle.

Targeting these factors with specific antagonists during the early or mid-luteal phase is necessary to observe the suppression of luteal function and vascular development.

Endothelial cell proliferation data acts as a quantitative marker to track the intensity of vascular growth from the pre-antral follicle stage to the early corpus luteum.

Related Experiment Videos

Main Methods:

Review approach involves utilizing marmoset monkeys to evaluate cellular and molecular control of vascular expansion. Researchers quantify vessel area and endothelial cell division across distinct stages of the cycle. The team monitors expression profiles of putative regulatory proteins within ovarian structures. Investigators administer specific antagonists in vivo to disrupt identified signaling pathways. This strategy allows for the assessment of functional consequences following factor blockade. The design focuses on comparing treated subjects against baseline physiological conditions. Scientists track changes during the pre-antral, follicular, and luteal phases. This systematic procedure enables the elucidation of how growth factors influence reproductive tissue development.

Main Results:

Key findings from the literature demonstrate that vascular growth begins in the pre-antral follicle and peaks during the early corpus luteum. Data show that VEGF serves as a primary regulator synthesized by developing follicles. Administration of specific antagonists causes a significant reduction in endothelial cell division within the follicle. This decrease correlates with a marked decline in granulosa cell proliferation. Inhibition during early or mid-luteal phases leads to the suppression of luteal vascularization. The results reveal a failure in the development of the microvascular tree under these conditions. Blocking these pathways consistently results in the suppression of luteal function. These observations confirm the necessity of VEGF for maintaining normal ovarian vascular integrity.

Conclusions:

The authors propose that targeting vascular growth factors offers a promising strategy for modulating reproductive outcomes. Synthesis and implications suggest that inhibiting these signals disrupts the formation of the microvascular network. Findings indicate that such interventions suppress the functional capacity of the corpus luteum. The evidence implies that vascular development is linked to the proliferation of granulosa cells. Researchers conclude that manipulating these pathways could potentially alter the progression of ovulation. The work highlights the importance of precise timing when applying angiogenic antagonists. These results provide a foundation for future reproductive health therapies. The study confirms that the marmoset serves as an effective model for testing these regulatory mechanisms.

Angiogenesis is measured by quantifying blood vessel area and monitoring the expression patterns of regulatory factors within the developing follicle and corpus luteum.

The authors suggest that manipulating these pathways represents a novel approach to either promote or inhibit normal processes like folliculogenesis and ovulation.